Synapse - Andrew Seidman

Results (12)

A phase I trial of sorafenib with whole brain radiotherapy (WBRT) in breast cancer patients with brain metastases and a correlative FLT-PET brain imaging study in patients receiving WBRT +/- sorafenib

Meeting Abstract

Morikawa, A.; Grkovski, M.; Patil, S.; Jhaveri, K.; Tang, K.; Humm, J.; Holodny, A.; Beal, K.; Schoder, H.; Seidman, A.
Neuro-Oncology Advances (2019)

Fulltext@MSK | Save

CONTESSA: A multinational, multicenter, randomized, phase III registration study of tesetaxel plus a reduced dose of capecitabine in patients (pts) with HER2-, hormone receptor plus (HR plus ) locally advanced or metastatic breast cancer (LA/MBC) who have previously received a taxane

Meeting Abstract

O'Shaughnessy, J.; Piccart, M.; Schwartzberg, L. S.; Cortes, J.; Harbeck, N.; Im, S. A.; Rugo, H. S.; Untch, M.; Yardley, D. A.; Bondarenko, I.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

ATTAIN: Phase III study of etirinotecan pegol versus treatment of physician's choice in patients with metastatic breast cancer and brain metastases

Journal Article

Tripathy, D.; Tolaney, S. M.; Seidman, A. D.; Anders, C. K.; Ibrahim, N.; Rugo, H. S.; Twelves, C.; Dieras, V.; Muller, V.; Tagliaferri, M.; more...
Future Oncology (2019)

Fulltext@MSK | Save

Influence of prognostic factors on outcomes among metastatic breast cancer patients treated with CDK4&6 inhibitors in routine clinical practice

Meeting Abstract

Saverno, K. R.; Carter, G. C.; Li, L.; Battiato, L. A.; Huang, Y. J.; Smyth, E. N.; Price, G. L.; Sheffield, K. M.; Baxi, S. S.; Kuk, D.; more...
Cancer Research (2019)

Fulltext@MSK | Save

A phase I trial of sorafenib with whole brain radiotherapy (WBRT) in breast cancer patients with brain metastases and a correlative study of FLT-PET brain imaging in patients receiving WBRT with or without sorafenib

Meeting Abstract

Morikawa, A.; Jhaveri, K.; Grkovski, M.; Tang, K.; Humm, J. L.; Holodny, A.; Beal, K.; Schoder, H.; Seidman, A. D.
Cancer Research (2019)

Fulltext@MSK | Save

Chemotherapy-induced peripheral neuropathy in breast cancer survivors: Comparison of objective and subjective measures

Meeting Abstract

Bao, T.; Kwon, A.; Piulson, L.; Chen, P.; Li, Q.; Patil, S.; Seidman, A.; Blinder, V.; Vahdat, L.; Zhi, W. I.; more...
Cancer Research (2019)

Fulltext@MSK | Save

Adjuvant chemotherapy for node negative, high Recurrence Score(TM) breast cancer: In defense of de-escalation

Editorial

Lake, D.; Seidman, A. D.
npj Breast Cancer (2019)

Fulltext@MSK | Save

Phase I study of intermittent high-dose lapatinib alternating with capecitabine for HER2-positive breast cancer patients with central nervous system metastases

Journal Article

Morikawa, A.; de Stanchina, E.; Pentsova, E.; Kemeny, M. M.; Li, B. T.; Tang, K.; Patil, S.; Fleisher, M.; Van Poznak, C.; Norton, L.; more...
Clinical Cancer Research (2019)

Fulltext@MSK | Save

Summary of head-to-head comparisons of patient risk classifications by the 21-gene Recurrence Score® (RS) assay and other genomic assays for early breast cancer